Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Heterozygous alpha 1-antitrypsin phenotypes in patients with end stage liver disease.

The American journal of gastroenterology - 1 Apr 1997

Eigenbrodt M L, McCashland T M, Dy R M, Clark J, Galati J

Abstract excerpt

OBJECTIVE: The objective of the study was to determine the prevalence and associations of abnormal alpha1-antitrypsin phenotypes in Caucasian adults with end stage liver disease with particular emphasis on heterozygous phenotypes and disease from hepatitis C virus. METHODS: All patients (788) wit...

Topics

Adult
Analysis of Variance
Chronic Disease
Confidence Intervals
Female
Heterozygote
Humans
Liver Failure
Liver Transplantation
Male
Middle Aged
Odds Ratio
Phenotype
Prevalence
Retrospective Studies
United States
White People
alpha 1-Antitrypsin

Source

Open in PubMed

Identifiers

PMID: 9128307

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9128307-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics